Avivagen: The OxC-Beta™ Technology

Jul 1, 2019 | Projects

ABOUT

CLIENT: Avivagen develops science-based, natural health products for animals that are proven in clinical trials and offer veterinarians real alternatives to traditional treatments.

SERVICE:From 3DforScience, we produced a 3D scientific animation explaining that Avivagen is developing and commercializing products that promote health in animals and humans. We explain Avivagen Technology call OxC-beta™ technology, it is a proprietary, first-in-class source of β-carotene-oxygen copolymer compounds that confer a variety of non-vitamin A health benefits.

These benefits have wide, global utility, including replacement of antibiotics in livestock feeds, as well as for food-production conditions where antibiotics cannot be used, and supporting good health in companion animals.

OxC-beta: Improving Health by Enhancing Immune Defences

Avivagen’s discovery of the existence of β-carotene-oxygen copolymers as the main product of the spontaneous, non-enzymatic oxidation of β-carotene in air, together with their role as the actual source of non-vitamin A effects, has opened up major product opportunities.

β-carotene copolymer active compound In Avivagen’s commercial productsThe β-carotene copolymer active compound In Avivagen’s commercial products is most conveniently and economically provided in the form of fully oxidized β-carotene (OxBC), produced synthetically by a global β-carotene manufacturer. Synthetic OxBC is the richest and purest source of β-carotene-oxygen copolymer compound (85% by weight); the presence of very minor amounts of numerous co-generated, low molecular weight, norisoprenoid compounds reflect the oxidation process as it occurs naturally in plant materials.oxigen and carotene

Commercial OxBC formulations include OxC-beta™ Livestock premix for livestock feeds and Vivamune™ Health Chews supplements for companion animals. To explain this complex scientific process the 3DforScience team has developed in a high quality animation to clarify

The absence of both β-carotene and vitamin A in the OxC-beta™ products has permitted clear, unambiguous demonstrations of the non-vitamin A benefits of the β-carotene copolymer compound that previously were thought to arise from vitamin A or intact β-carotene itself.

In livestock, the health benefits of the β-carotene copolymer have been clearly shown in various trials with poultry, swine and dairy cattle, using low parts-per-million levels of the compound in feed. Better health translates into better productivity.

In companion animals such as canines, health benefits are observed in a variety of ways that depend on the individual health status of the animals.

Avivagen’s scientific publications support an immunological basis underlying the variety of health benefits observed in animals, it being understood that the β-carotene copolymer becomes effective when the immune system is in less than optimal condition, as is often the situation.

CaroteneThe OxC-beta™ first-in-class line of products now provide livestock producers and pet owners alike access to the actual source of non-vitamin A function, providing consistent and reliable results in enhancing the health of their animals.

How can 3DforScience help you?

3DforScience is a scientific communication company specialized in digital content for the pharma and biotech industries. Our passionate creative team works alongside an in-house scientific team to provide cutting-edge medical animations, scientific illustrations, virtual reality, etc.

Our extensive experience within the field ensures all the content we produce is scientifically accurate, innovative, engaging, and pitched at the right level for the target audience. Would you like to bring your scientific messaging to life? Contact us. We would love to help you create something unique.

ARE YOU INTERESTED IN SCIENTIFIC ANIMATION AND COMMUNICATION?

Related news

High performance sustainable material: Sappi Symbio

High performance sustainable material: Sappi Symbio

Sappi is a global company focused on providing dissolving pulp, paper pulp, paper-based and biorefinery solutions to its customers in over 150 countries. They invest in research and development programs, unlocking the true potential of sustainable renewable resources,...

cPass™ technology by GenScript

cPass™ technology by GenScript

Coronaviruses are a large family of viruses that may cause illness in animals or humans.  In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS)...

B2B device: from breast to bone

B2B device: from breast to bone

ABOUT CLIENT: B2B is an EU-funded project that aims to develop a breakthrough technology that for the first time dissects the steps of spontaneous breast cancer metastasis to the bone and captures the 3D complexity of the process. The project started in July 2018,...